The ALF National Legacy Gala on October 7, 2024, at Gotham Hall, NYC, will bring together patients, families, thought leaders, medical professionals, business visionaries, and partners to celebrate impactful contributions to the liver community, raising awareness and funds for liver disease.
This Sunday, September 8th, is International PBC Awareness Day and American Liver Foundation (ALF) is encouraging everyone to know the facts and warning signs of this autoimmune liver disease.
After being diagnosed with nonalcoholic fatty liver disease (NAFLD), Manny learned all he could about the disease, including how the prevalence of NAFLD is higher in U.S. Hispanic populations. As a second generation Mexican American, Manny is on a mission to raise awareness in the Hispanic community and encourage people to get screened before it is too late. Read Manny’s story now.
American Liver Foundation (ALF) announced new liver research awards for 2024 that will fund early career scientists interested in basic and translational research.
After experiencing the gaps in health equity firsthand, Evelyn, a two-time liver transplant recipient and proud multi-generational New Mexican, advocates to raise awareness of liver disease and increase access to liver healthcare and transplant in minority and rural populations.
Liver disease affects more than 100 million Americans, yet federal investment in early diagnosis, prevention, treatment and research continue to lag far behind other chronic diseases. This summer, American Liver Foundation (ALF) advocates will meet virtually and in-person with elected officials in their local cities and towns to share their liver stories and lend their voices to urge action.
American Liver Foundation (ALF) announces a new Project Echo program for healthcare providers that will bring treatment and prevention best practices for nonalcoholic fatty liver disease (NAFLD)* to non-liver experts.
American Liver Foundation (ALF) announced the first-ever patient registry for all types of liver disease. The American Liver Foundation Patient Registry will help provide researchers with a better understanding of liver diseases, the impact of current treatments, and how liver disease affects patients.
ALF's Red, White and Blue salad is a healthy and festive way to celebrate America's Independence this Fourth of July!
Jessie had no idea she was born with a rare, chronic liver disease until she found herself in a desperate fight for her life and needed a transplant to survive. Learn more about Jessie's story and the importance of raising awareness about liver health and organ donation.
Though anyone can be affected, men are more prone to certain types of liver conditions. And while there are many causes […]
The Treat and Reduce Obesity Act (TROA) of 2023 is a pivotal piece of legislation that seeks to establish Medicare Part D coverage for FDA-approved anti-obesity medications and intensive behavioral therapy. This Act is not just about treating obesity; it's about preventing severe liver diseases that can arise as a result.